Blockbuster Therapy Predictor

Predict which early-stage biotechnology platforms (PROTAC, mRNA, gene editing, etc.) have the highest potential to become blockbuster therapies. Analyzes clinical trial progression, patent landscape maturity, and venture capital funding trends to generate investment and R&D prioritization scores. Trigger when: User asks about technology investment potential, platform selection, or therapeutic modality comparison.

Comprehensive analytics tool for forecasting breakthrough therapeutic technologies by integrating multi-dimensional data sources including clinical development pipelines, intellectual property landscapes, and capital market indicators.

Features

• Multi-Source Data Integration: Aggregates clinical trials, patents, and funding data
• Predictive Scoring: Calculates Blockbuster Index combining maturity, market potential, and momentum
• Technology Landscape Mapping: Tracks 10+ emerging therapeutic platforms
• Investment Intelligence: Provides data-driven R&D and investment recommendations
• Trend Analysis: Identifies acceleration patterns and inflection points

Usage

Basic Usage

bash

# Run complete analysis with all technologies
python scripts/main.py

# Analyze specific technologies
python scripts/main.py --tech PROTAC,mRNA,CRISPR

# Output in JSON format
python scripts/main.py --output json

Parameters

Parameter	Type	Default	Required	Description
--mode	str	full	No	Analysis mode: full or quick
--tech	str	None	No	Comma-separated list of technologies to analyze
--output	str	console	No	Output format: console or json
--threshold	float	0	No	Minimum blockbuster index threshold (0-100)
--save	str	None	No	Save report to file path

Advanced Usage

bash

# Analyze high-potential technologies only (index ≥70)
python scripts/main.py \
  --threshold 70 \
  --output json \
  --save high_potential_report.json

# Quick analysis of specific platforms
python scripts/main.py \
  --mode quick \
  --tech CAR-T,ADC,Bispecific \
  --output console

Output

Console Output

text

🏆 BLOCKBUSTER THERAPY PREDICTOR Report
Generated: 2026-02-15 10:30:00
Technologies analyzed: 10

📊 Technology Rankings
Rank  Technology       Blockbuster Index    Maturity    Market Potential    Momentum    Recommendation
🥇 1   mRNA             85.2                 78.5        92.1                88.0        Strongly Recommended
🥈 2   CAR-T            82.3                 85.2        78.5                75.0        Strongly Recommended
🥉 3   CRISPR           79.8                 72.3        88.2                68.0        Recommended

JSON Output Structure

json

{
  "generated_at": "2026-02-15T10:30:00",
  "total_routes": 10,
  "rankings": [
    {
      "rank": 1,
      "tech_name": "mRNA",
      "blockbuster_index": 85.2,
      "maturity_score": 78.5,
      "market_potential_score": 92.1,
      "momentum_score": 88.0,
      "recommendation": "Strongly Recommended",
      "key_drivers": ["Multiple Phase III trials", "Rapid patent growth"],
      "risk_factors": ["Regulatory uncertainties"],
      "timeline_prediction": "First product expected in 2-4 years"
    }
  ]
}

Scoring Methodology

Blockbuster Index Formula

text

Blockbuster Index = (Market Potential × 0.5) + (Maturity × 0.3) + (Momentum × 0.2)

Component Scores

Component	Weight	Factors
Market Potential	50%	Market size, unmet need, competition
Maturity	30%	Clinical stage, patent depth, funding stage
Momentum	20%	Patent growth, funding activity, clinical progress

Investment Recommendation Thresholds

Blockbuster Index	Recommendation	Action
≥ 80	Strongly Recommended	Prioritize R&D investment
60-79	Recommended	Active monitoring and early partnerships
40-59	Watch	Monitor milestones; reassess in 6-12 months
< 40	Cautious	Minimal investment; consider divestment

Supported Technologies

Technology	Category	Description
PROTAC	Protein Degradation	Proteolysis Targeting Chimera
mRNA	Nucleic Acid Drugs	Messenger RNA therapy platform
CRISPR	Gene Editing	CRISPR-Cas gene editing technology
CAR-T	Cell Therapy	Chimeric Antigen Receptor T-cell therapy
Bispecific	Antibody Drugs	Bispecific antibody technology
ADC	Antibody Drugs	Antibody-Drug Conjugate
RNAi	Nucleic Acid Drugs	RNA interference therapy
Gene Therapy	Gene Therapy	AAV vector gene therapy
Allogeneic	Cell Therapy	Universal/Allogeneic cell therapy
Cell Therapy	Cell Therapy	General cell therapy platform

Technical Difficulty: MEDIUM

⚠️ AI自主验收状态: 需人工检查

This skill requires:

• Python 3.8+ environment
• Basic understanding of biotech investment analysis
• Access to clinical trial, patent, and funding databases (optional)

Dependencies

Required Python Packages

bash

pip install -r requirements.txt

Requirements File

text

dataclasses
enum

Risk Assessment

Risk Indicator	Assessment	Level
Code Execution	Python scripts executed locally	Medium
Network Access	No external API calls in mock mode	Low
File System Access	Read/write report files only	Low
Instruction Tampering	Standard prompt guidelines	Low
Data Exposure	Output files saved to workspace	Low

Security Checklist

• No hardcoded credentials or API keys
• No unauthorized file system access (../)
• Output does not expose sensitive information
• Prompt injection protections in place
• Input file paths validated (no ../ traversal)
• Output directory restricted to workspace
• Script execution in sandboxed environment
• Error messages sanitized (no stack traces exposed)
• Dependencies audited

Prerequisites

bash

# Python dependencies
pip install -r requirements.txt

Evaluation Criteria

Success Metrics

• Successfully executes main functionality
• Output meets quality standards
• Handles edge cases gracefully
• Performance is acceptable

Test Cases

1. Basic Functionality: Run without arguments → Expected output with all technologies
2. Technology Filter: Use --tech flag → Only specified technologies analyzed
3. JSON Output: Use --output json → Valid JSON format output
4. Threshold Filter: Use --threshold 70 → Only technologies with index ≥70 shown

Lifecycle Status

• Current Stage: Draft
• Next Review Date: 2026-03-15
• Known Issues: None
• Planned Improvements:
  • Integration with real-time data APIs
  • Additional technology platforms
  • Enhanced visualization capabilities

References

See references/ for:

• Historical blockbuster case studies
• Clinical trial data sources
• Patent analysis methodologies
• Investment scoring frameworks

Limitations

• Data Source: Uses mock data for demonstration; real-time data integration required for production use
• Prediction Accuracy: Model provides indicative scores; not investment advice
• Technology Coverage: Limited to pre-configured technology platforms
• Market Dynamics: Cannot predict black swan events or regulatory changes
• Regional Bias: Data primarily focused on US/EU markets

---

⚠️ DISCLAIMER: This tool provides quantitative analysis for decision support only. All investment and R&D decisions should incorporate qualitative domain expertise, regulatory consultation, and comprehensive due diligence. Past performance of historical blockbusters does not guarantee future success of emerging technologies.